NasdaqCM:ABEOBiotechs
Abeona Therapeutics (ABEO) One Off US$152.4m Gain Tests Bullish Profitability Narrative
Abeona Therapeutics (ABEO) closed FY 2025 with Q4 revenue of US$5.4 million and basic EPS of a US$0.37 loss, alongside a net income loss of US$20.5 million. Its trailing twelve month figures show basic EPS of US$1.34 and net income of US$71.2 million on revenue of US$5.8 million. Over recent quarters the company has reported revenue of US$0 in Q3 2025, US$0.4 million in Q2, and US$5.4 million in Q4, with quarterly basic EPS moving from a US$2.07 profit in Q2 to losses of US$0.10 in Q3 and...